Emtricitabine/tenofovir alafenamide - Gilead Sciences
At a glance
- Drug Originator Gilead Sciences
- Drug Licenced by Japan Tobacco
- Drug Class Antiretrovirals; Deoxyribonucleosides; Purines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Nucleotide reverse transcriptase inhibitors
- USA Patent Applicants GILEAD SCIENCES INC
- USA Patents 9
- NDAs 1
- International Patents 132
Table of Contents

Disclaimer